My licensee may be in financial difficulty. How can I protect my IP?


I think one of our licensees may have financial problems. Although I am reluctant to take drastic action that may sever our business relationship, how can I ensure that we protect our IP?

The lawyer

If you have a financially distressed licensee, the first step is deciding whether to terminate the licence. A distressed licensee can devalue your IP and limit your ability to grant licences to other, potentially better performing parties. If the licence is exclusive, all avenues to monetise the IP may be blocked. Even if not exclusive, other existing or future licensees may be deterred from paying because they would be disadvantaged in competing with a licensee who is not paying.

Additionally, it may be important to terminate if the licensee's precarious position creates a risk that competitors to whom you would never have licensed could get access to your technology through voluntary M&A activity or bankruptcy. This may be particularly important where trade secrets are involved, although some courts will issue orders protecting trade secrets to prospectively block such harmful releases of trade secrets.

If termination is necessary,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Our October issue is now available, featuring the first in a year-long series of articles on #UnitaryPatent & #UPC http://t.co/T4kMwki9eF

Sep 30 2014 09:31 ·  reply ·  retweet ·  favourite
ManagingIP profile

Useful case study on declarations of non-infringement in China: http://t.co/fCL4Qe1Qr3 (sponsored)

Sep 30 2014 08:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

A guide to pharmaceutical data exclusivity in China: http://t.co/T3eEIdvzo8 (sponsored)

Sep 30 2014 08:34 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPPI Congress News 2014

Read this year's AIPPI Congress News - published daily by Managing IP direct from the AIPPI Annual Meeting in Toronto
null null null

October 2014

What we want from the Unitary Patent and UPC

The EU Unitary Patent and Unified Patent Court are set to launch within the next 18 months. In the first article of a year-long series, Emma Barraclough and James Nurton gauge the expectations and concerns of in-house counsel



Most read articles

Supplements